Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $11.03 Analyst target: $23.80 Upside: 115.78%
Arcturus Therapeutics Holdings Inc., an RNA drug company, focuses on the treatment of liver and respiratory diseases. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.